This inventor holds 3 USPTO granted patents and 4 published patent applications and 2 EPO patents. Top assignee: Health Research, Inc.. Active years: 2018-2021.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2018-2021
Title: The Innovative Contributions of Lu Yang
Introduction
Lu Yang is a prominent inventor based in Buffalo, NY (US), known for his significant contributions to the field of cancer research. With a total of 3 patents, he has developed groundbreaking methods for the prophylaxis and treatment of specific types of cancers. His work is instrumental in advancing therapeutic options for patients at risk of ErbB2 and ErbB1 positive cancers.
Latest Patents
Lu Yang's latest patents include innovative methods aimed at combating ErbB2 and ErbB1 positive cancers. The first patent, titled "Method for prophylaxis and/or treatment of ErbB2 positive cancers," provides compositions and methods for the therapy of ErbB2-positive cancer. This patent includes pharmaceutical preparations that contain isolated or recombinant or modified peptidase D (PEPD) proteins. The methods outlined involve administering a PEPD to individuals who have or are at risk for developing ErbB2-positive cancer. The second patent, "Method for prophylaxis or treatment of ErbB1 positive cancers using a variant peptidase D with reduced activity," similarly focuses on ErbB1-positive cancer. It also includes pharmaceutical preparations with PEPD proteins and outlines methods for administering these to individuals at risk for ErbB1-positive cancer.
Career Highlights
Lu Yang is currently associated with Health Research, Inc., where he continues to innovate and contribute to cancer research. His work has garnered attention for its potential to improve treatment outcomes for patients suffering from these aggressive forms of cancer.
Collaborations
Lu Yang collaborates with esteemed colleagues in his field, including Yuesheng Zhang and Yun Li, who contribute to the research and development of his innovative methods.
Conclusion
Lu Yang's contributions to cancer research through his patents and collaborations highlight his commitment to improving therapeutic options for patients. His innovative methods represent a significant advancement in the fight against ErbB2 and ErbB1 positive cancers.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile